To further validate WT1 upregulation in fibroblasts of IPF lungs, we conducted RNA ISH for WT1 and ACTA2, a well-established myofibroblast marker, in control and IPF lung tissues. This evidence concerns the gene WT1 and idiopathic pulmonary fibrosis.